An application made for this job — a tailored resume and cover letter that speak straight to the posting.
CSL in Maidenhead (UK) is seeking an Intake Lead for Adverse Events to oversee the vendor responsible for logging and triaging every case. You will ensure correct capture, timely processing, and adherence to global regulatory guidelines, influencing downstream pharmacovigilance activities.
The role is hybrid—3 days on site in Maidenhead—with a strong focus on process governance, training, and audit readiness. A life sciences degree and PV experience are essential to succeed.
Every adverse event report that reaches CSL — from a treating physician, a license partner, a regulatory authority — starts its life in one place: intake. This role owns the quality of that starting point. You'll oversee the vendor responsible for logging and triaging every report that lands in CSL's Global Adverse Events Inbox, making sure each one is captured accurately, on time, and in line with global regulatory requirements. It's a role built on the principle that everything downstream in pharmacovigilance — every safety signal, every regulatory submission — is only as reliable as the intake that fed it.
Based in Maidenhead, UK. Hybrid, 3 days a week on site
Regulators don't forgive a missed or mishandled adverse event report, and neither should the systems built to catch them. This role sits at the point where CSL's global safety obligations either hold or don't. Getting intake right — consistently, across every source and every market — is what keeps CSL's regulatory standing intact and, more fundamentally, what keeps the signal-detection process that protects patients working as it should.
You'll be the standard-bearer for how intake gets done — not performing the work yourself, but making sure the vendor who does performs it to the letter of CSL's processes, PV agreements, and global regulatory guidelines. You'll build the guidance that governs their work, train them against it, and be the person accountable when regulators or auditors come asking how the process holds up.